IM Cannabis Corp.
Close on Oct 19, 2026
About IM Cannabis
Medicinal Chemicals & Botanical Products, SIC 2833
The company operates in the medical cannabis industry, engaging in the cultivation, processing, marketing, and distribution of cannabis products. Its offerings include bulk cannabis, packaged dried cannabis, and other cannabis-derived products, along with medical herb distribution. Operating through pharmacy entities such as Oranim and Rayarok Pharm, as well as holding interests in entities like Focus and Adjupharm, the business serves retail customers, pharmacies, and medical patients seeking cannabis products and related healthcare supplies.
The enterprise conducts operations across international markets, maintaining business segments and activities located in Israel, Germany, and Canada. Its operational infrastructure includes cultivation facilities, leasehold premises, pharmacies, and licensed processing entities. The provided annual report text references corporate entities and operating activities across these jurisdictions, but it does not specify a single global headquarters location or precise store counts.
Summary of the business section of IM Cannabis's latest annual report, written by StockData.
Company profile
Company
- Legal name
- IM Cannabis Corp.
- Headquarters
- Central District, L3
- Address
- Kibbutz Glil Yam 4690500
- Phone
- (416) 256-4202
- Employees
- 95, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- KOST FORER GABBAY & KASIERER, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- IMCC
- Exchange
- Nasdaq
- Shares outstanding
- 6M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-30 reverse, Aug 27, 2026; 1-for-6 reverse, Mar 31, 2025; 1-for-6 reverse, Jul 12, 2024; 1-for-10 reverse, Mar 29, 2023; 1-for-10 reverse, Nov 17, 2022
- SEC CIK
- 1792030
- CUSIP
- 44969Q505
- ISIN
- US44969Q5053
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
IM Cannabis's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“The following table sets forth the number of employees we had at the end of each fiscal period: … - 95”